Mr. John Luna reports

LIGHT AI APPOINTS CFO AND CORPORATE SECRETARY

Light AI Inc. has appointed Mark Orsmond as chief financial officer and corporate secretary of the company, replacing George Reznik who resigned as chief financial officer and corporate secretary on Jan. 26, 2026. Mr. Reznik continued as a part-time consultant until March 27, 2026.

Mark Orsmond -- chief financial officer and corporate secretary: Mr. Orsmond is a business and finance professional offering over 25 years of demonstrated expertise and success in leading, managing and growing businesses to become large, global enterprises. Mr. Orsmond was the original founder of the capital pool company that eventually developed into Well Health Technologies Inc., following its qualifying transaction in 2016 with Canada Yoga Inc. Mr. Orsmond has subsequently led the sale of three entities to Well. Mr. Orsmond was CFO and executive vice-president of the Corix Group of Companies, which is one of North America's leading water companies operating in over 30 U.S. states and three Canadian provinces. At Corix, Mr. Orsmond managed a team of 45 accounting and finance professionals and managed a treasury of over $1.6-billion. Mr. Orsmond was CFO and executive VP of the ALL-SEA Group of Companies, where over a 10-year period, he assisted in developing the company into one of the world's leading underwater high-tech maintenance companies before it was sold to a United States private equity group in 2017. Over the last few years, he has been focused on EV (electric vehicle) technologies where he acted as chief financial officer of Taiga Motors Corp. (Toronto Stock Exchange: TAIG) and the former ElectraMeccanica (Nasdaq: SOLO), raising over $200-million. He is currently doing fractional consulting work for Orsim Finance Ltd.

"We are strengthening Light AI at a pivotal stage in our growth. Mark brings deep financial discipline and operational scaling experience across technology and health care. This appointment enhances our ability to execute with rigor as we advance commercialization, align capital strategy and build long-term shareholder value. We thank George Reznik for his service and contributions," says John R. Luna, chief executive officer.

Steve Semmelmayer, chair of the board, further states: "This is a deliberate step to align Light AI's leadership with the next phase of disciplined execution and market expansion. Mark's track record in scaling finance functions within complex, growth-stage environments. On behalf of the board, I would also like to thank George Reznik for his contributions to the company and wish him continued success."

The company also wishes to announce that Mark Attanasio tendered his resignation as a director of the company. The company thanks Mr. Attanasio for his service as a member of the board.

About Light AI Inc.

Light AI is a technology company focused on developing artificial intelligence health screening and diagnostic solutions. Light AI QuickScan is a technology platform which represents the next generation of patient management: it applies AI algorithms to compatible smart device images, starting with images of Strep A and anticipated expansion with other medical conditions, to identify the disease in seconds. Its patented, app-based solution requires no swabs, lab tests or proprietary hardware of any kind as its computing platform includes the 4.5 billion smart phones that exist in the world today. Light AI is at the forefront of developing innovative screening and diagnostic solutions aimed at improving health care delivery worldwide. Their cutting-edge AI powered technology offers rapid, accurate, and cost-effective screening and diagnostic tools designed to address critical health care challenges.

In pre-FDA (Food and Drug Administration) validation studies, Light AI's algorithm demonstrated remarkable accuracy in differentiating between viral and bacterial pharyngitis, specifically targeting Group A Streptococcus (GAS). The algorithm achieved a 96.57-per-cent accuracy rate and attained a negative predictive value of 100 per cent, indicating its high reliability in confirming the absence of Streptococcus A infection. Viral and GAS pharyngitis affects over 600 million people annually worldwide. If left untreated, GAS pharyngitis can lead to serious complications such as Rheumatic Heart Disease (RHD), which imposes a global economic burden exceeding $1-trillion annually. Light AI's technology offers a significant advancement in the accurate and timely identification of GAS pharyngitis, potentially reducing the incidence of RHD and its associated costs. Light AI's approach to applying AI to smart device images can be expanded to other medical conditions, as well as other areas of analysis. Light AI's vision is to combine the Light Ai QuickScan software platform with AI in the cloud to create a digital clinical lab that provides quick and accessible diagnosis for countless conditions that today require expensive and time-consuming imaging or lab processes.

We seek Safe Harbor.